Caricamento...
Molecular monitoring of chronic myeloid leukemia: present and future
INTRODUCTION: Fusion of BCR-ABL1 genes causes chronic myeloid leukemia (CML). As a reliable marker of disease burden, it also serves as the target of tyrosine kinase inhibitors (TKIs). New more sensitive molecular diagnostic tools for BCR-ABL1 can contribute to therapeutic decision-making, especiall...
Salvato in:
| Pubblicato in: | Expert Rev Mol Diagn |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5161535/ https://ncbi.nlm.nih.gov/pubmed/27552202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14737159.2016.1227243 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|